查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1865418

全球营养基因体学检测套组市场：预测至2032年－按组件、样本类型、部署方法、测试类型、技术、应用和地区进行分析

Nutrigenomic Testing Kits Market Forecasts to 2032 - Global Analysis By Component, Sample Type, Deployment Mode, Test Type, Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球营养基因组学检测套组市场预计到 2025 年将达到 6,690 万美元，到 2032 年将达到 1.836 亿美元，预测期内复合年增长率为 15.5%。

营养基因组学检测套组分析个体的基因组成，以评估身体对特定营养素、饮食模式和生活方式因素的反应。透过检测基因与营养素的相互作用，这些试剂盒能够提供关于新陈代谢、食物敏感性和营养吸收的个人化见解。检测结果指南制定个人化的营养和健康策略，旨在优化健康。营养基因组学检测通常用于预防保健和个人化营养规划，为符合个体独特基因特征和潜在易感性的实证饮食建议提供支持。

根据 2020 年发表在《营养素》（MDPI）杂誌上的一篇评论，全球消费者营养基因检测市场估计有 250 多家公司，其中 100 多家公司提供基于基因谱的个性化饮食建议，这反映了基因营养策略的快速商业化和消费者日益增长的兴趣。

越来越多的消费者希望获得基于DNA的饮食建议。

利用基因检测帮助人们了解自身营养代谢、食物敏感性以及根据基因量身定制的最佳饮食方案，正成为日益流行的趋势。健康生活方式和预防性医疗保健策略的兴起进一步推动了这一趋势。数位平台和行动医疗应用程式正在扩大服务的可及性，使用户能够远端获得个人化的营养建议。随着人们对基因与饮食之间相互作用的认识不断加深，无论是在临床管道还是面向消费者的管道，市场都呈现出消费者兴趣激增的态势。

临床检验和标准化程度有限

许多试剂盒依赖尚未被监管机构或临床医生广泛接受的新兴研究。这种不确定性影响了消费者的信心，并限制了其融入主流医疗保健系统。此外，不同机构在实验室调查方法和解读框架上的差异也造成了混乱，阻碍了结果的可比较性。如果没有可靠的临床试验和公认的指南，该市场可能被视为投机性强于实证医学。

与预防保健计划结合

营养基因组学检测正日益成为预防性医疗保健框架中的积极工具。透过识别肥胖、糖尿病、心血管疾病等疾病的遗传易感性，这些检测试剂盒能够实现早期饮食干预，从而降低长期健康风险。医疗保健机构和保险公司正在探索合作，将基因营养筛检纳入常规健康计画。此外，企业健康计画和健身平台也正在利用营养基因组学见解来改善个人化指导和饮食计画。

科学怀疑论和错误讯息

批评者认为，许多基因与饮食的关联仍未有定论或过度简化，可能导致误导。不准确的营销宣传和缺乏透明度的检测结果解读可能会损害消费者的信任。此外，未经监管的直接面向消费者（DTC）检测套组的激增引发了人们对数据准确性和基因资讯伦理使用的担忧。如果没有透过严格的检验和清晰的沟通来解决这些问题，质疑声音可能会减缓市场成长和监管核准。

新冠疫情的影响：

新冠疫情加速了人们对居家健康监测（包括基因营养检测）的兴趣。由于线下咨询受限，消费者转向远距离诊断和个人化健康管理工具。人们希望透过个人化饮食来优化免疫力并控制慢性疾病，这导致对营养基因组学试剂盒的需求激增。然而，供应链中断和检查室能力下降暂时影响了试剂盒的供应和检测结果的出具时间。

预计在预测期内，全EXOME/基因组检测套组细分市场将占据最大的市场份额。

由于其全面的基因覆盖范围和诊断深度，全EXOME/全基因组检测套组盒预计将在预测期内占据最大的市场份额。这些试剂盒能够分析更广泛的基因变异，深入了解营养代谢、疾病风险和饮食反应。其应用范围涵盖临床营养、研究和个人化医疗，使其用途广泛。定序技术和数据解读的进步提高了检测的准确性和可负担性，进一步推动了此类试剂盒的普及。

预计在预测期内，药物基因组学领域将实现最高的复合年增长率。

由于药物基因组学在优化药物-营养相互作用方面发挥重要作用，预计在预测期内，该领域将迎来最高的成长率。该领域专注于研究基因变异对个别药物和补充剂反应的影响，从而製定更安全有效的治疗方案。人们对膳食补充剂和机能性食品日益增长的兴趣，推动了对药物基因组学见解的需求，以指导个人化补充。与电子健康记录和临床决策支援系统的整合也进一步拓展了效用。

占比最大的地区：

预计北美将在预测期内占据最大的市场份额，这得益于其完善的医疗保健基础设施和较高的消费者意识。该地区受益于基因技术的早期应用、主要市场参与者的强大影响力以及有利的报销政策。监管政策的明朗化和直接面向消费者（DTC）平台的广泛应用进一步加速了市场渗透。此外，文明病的日益增加以及人们对预防性营养的日益关注，也推动了对个人化饮食解决方案的需求。生技公司与健康服务提供者之间的策略联盟持续塑造区域市场格局。

预计年复合成长率最高的地区：

在预测期内，北美预计将实现最高的复合年增长率，这主要得益于医疗保健覆盖范围的扩大、可支配收入的增加以及人们对个性化健康日益增长的兴趣。中国、印度和韩国等国在营养管理和慢性病管理方面，基因检测的应用正不断普及。政府推动数位健康和​​预防医学的倡议，为市场扩张创造了有利条件。本土Start-Ups公司和国际公司都在投资开发适应不同文化背景的营养基因组学解决方案，以满足多样化的饮食习惯和基因特征。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球营养基因体学检测套组市场（按组件划分）

  • 介绍
  • 基因型鉴定盒
  • 全外EXOME/基因组检测套组
  • 生物标记组合
  • 软体和报告平台
  • 配套行动应用
  • 其他部件

6. 全球营养基因体学检测套组市场（依样本类型划分）

  • 介绍
  • 唾液
  • 血
  • 头髮
  • 口腔拭子
  • 其他样本类型

7. 全球营养基因体学检测套组市场依部署类型划分

  • 介绍
  • 直接面向消费者（DTC）
  • 临床管理
  • 仅供研究使用 (RUO)
  • 药局

8. 全球营养基因体检测套组市场（依测试类型划分）

  • 介绍
  • 营养反应
  • 药物基因体学
  • 微量营养素和维生素代谢
  • 体重管理和肥胖症小组
  • 健身、运动反应测试
  • 个人化补充剂推荐引擎
  • 其他类型的测试

9. 全球营养基因体学检测套组市场（依技术划分）

  • 介绍
  • SNP基因基因型鉴定
  • 全基因组序列分析
  • 微阵列
  • 次世代定序
  • 其他技术

第十章 全球营养基因体检测套组市场（按应用划分）

  • 介绍
  • 个人化营养和饮食计划
  • 临床营养支持
  • 体重管理计划
  • 运动表现与运动员优化
  • 慢性病风险评估（糖尿病、心血管疾病）
  • 研究和临床试验
  • 其他用途

第十一章 全球营养基因体学检测套组市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：公司简介

  • 23andMe
  • AncestryDNA
  • Nutrigenomix
  • DayTwo
  • Genova Diagnostics
  • Quest Diagnostics
  • Invitae
  • Myriad Genetics
  • Helix
  • LifeDNA
  • Viome
  • Onegevity
  • Atlas Biomed
  • Coral Genomics
  • Pathway Genomics
  • Medichecks
  • Biotronik
  • NIPD Genetics
  • Omixon
Product Code: SMRC32084

According to Stratistics MRC, the Global Nutrigenomic Testing Kits Market is accounted for $66.9 million in 2025 and is expected to reach $183.6 million by 2032 growing at a CAGR of 15.5% during the forecast period. Nutrigenomic testing kits analyze an individual's genetic makeup to assess how their body responds to specific nutrients, dietary patterns, and lifestyle factors. By examining gene-nutrient interactions, these kits provide personalized insights into metabolism, food sensitivities, and nutrient absorption. The results help guide tailored nutrition and wellness strategies aimed at optimizing health outcomes. Typically used in preventive healthcare and personalized nutrition planning, nutrigenomic testing supports evidence-based dietary recommendations aligned with an individual's unique genetic profile and potential predispositions.

According to a 2020 review published in Nutrients (MDPI), the global direct-to-consumer nutrigenetic testing market was estimated to exceed 250 companies, with over 100 offering personalized dietary recommendations based on genetic profiles, reflecting rapid commercialization and growing consumer interest in gene-based nutrition strategies.

Market Dynamics:

Driver:

Consumers increasingly seeking DNA-based dietary recommendations

Individuals are increasingly turning to genetic profiling to understand nutrient metabolism, food sensitivities, and optimal diet plans tailored to their unique genetic makeup. This trend is further supported by the rise of health-conscious lifestyles and preventive care strategies. Digital platforms and mobile health apps are amplifying accessibility, allowing users to receive customized nutrition advice remotely. As awareness of gene-diet interactions expands, the market is witnessing a surge in consumer interest across both clinical and direct-to-consumer channels.

Restraint:

Limited clinical validation and standardization

Many kits rely on emerging research that has yet to be universally accepted by regulatory bodies or clinical practitioners. This ambiguity affects consumer confidence and limits integration into mainstream healthcare. Moreover, variations in testing methodologies and interpretation frameworks across providers create confusion and hinder comparability. Without robust clinical trials and consensus guidelines, the market risks being perceived as speculative rather than evidence-based.

Opportunity:

Integration with preventive healthcare programs

Nutrigenomic testing is increasingly being positioned as a proactive tool within preventive healthcare frameworks. By identifying genetic predispositions to conditions like obesity, diabetes, and cardiovascular disease, these kits enable early dietary interventions that can mitigate long-term health risks. Healthcare providers and insurers are exploring partnerships to incorporate genetic nutrition screening into routine wellness programs. Additionally, corporate wellness initiatives and fitness platforms are adopting nutrigenomic insights to enhance personalized coaching and dietary planning.

Threat:

Scientific skepticism and misinformation

Critics argue that many genetic-diet associations are still inconclusive or oversimplified, leading to potential misinformation. Inaccurate marketing claims and lack of transparency in test interpretation can erode consumer trust. Furthermore, the proliferation of unregulated DTC kits raises concerns about data accuracy and ethical use of genetic information. If not addressed through rigorous validation and clear communication, skepticism may slow market growth and regulatory acceptance.

Covid-19 Impact:

The COVID-19 pandemic accelerated interest in home-based health monitoring, including genetic nutrition testing. With limited access to in-person consultations, consumers turned to remote diagnostics and personalized wellness tools. Nutrigenomic kits gained traction as individuals sought to optimize immunity and manage chronic conditions through tailored diets. However, supply chain disruptions and reduced laboratory capacity temporarily affected kit availability and turnaround times.

The whole exome/genome test kits segment is expected to be the largest during the forecast period

The whole exome/genome test kits segment is expected to account for the largest market share during the forecast period propelled by, its comprehensive genetic coverage and diagnostic depth. These kits analyze a broader range of genetic variants, enabling more detailed insights into nutrient metabolism, disease risk, and dietary response. Their application spans clinical nutrition, research, and personalized wellness, making them highly versatile. Technological advancements in sequencing and data interpretation are enhancing accuracy and affordability, further driving adoption.

The pharmacogenomics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmacogenomics segment is predicted to witness the highest growth rate, influenced by, its role in optimizing drug-nutrient interactions. This segment focuses on how genetic variations influence individual responses to medications and supplements, enabling safer and more effective therapeutic plans. Rising interest in nutraceuticals and functional foods is fueling demand for pharmacogenomic insights that guide personalized supplementation. Integration with electronic health records and clinical decision support systems is also expanding its utility in healthcare settings.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, fuelled by, by robust healthcare infrastructure and high consumer awareness. The region benefits from early adoption of genetic technologies, strong presence of key market players, and favorable reimbursement policies. Regulatory clarity and widespread availability of DTC platforms have further accelerated market penetration. Additionally, rising prevalence of lifestyle-related disorders and growing interest in preventive nutrition are driving demand for personalized dietary solutions. Strategic collaborations between biotech firms and wellness providers continue to shape the regional landscape.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, expanding healthcare access, rising disposable incomes, and growing interest in personalized wellness. Countries like China, India, and South Korea are witnessing increased adoption of genetic testing for nutrition and chronic disease management. Government initiatives promoting digital health and preventive care are creating fertile ground for market expansion. Local startups and international players are investing in culturally tailored nutrigenomic solutions, addressing diverse dietary habits and genetic profiles.

Key players in the market

Some of the key players in Nutrigenomic Testing Kits Market include 23andMe, AncestryDNA, Nutrigenomix, DayTwo, Genova Diagnostics, Quest Diagnostics, Invitae, Myriad Genetics, Helix, LifeDNA, Viome, Onegevity, Atlas Biomed, Coral Genomics, Pathway Genomics, Medichecks, Biotronik, NIPD Genetics, and Omixon.

Key Developments:

In October 2025, AncestryDNA launched its biggest ethnicity update to date. The update added 68 new European regions and re-analyzed all user DNA for improved accuracy. It now connects users to over 3,600 global ancestral locations.

In September 2025, Nutrigenomix partnered with Evexia Diagnostics to expand access to personalized nutrition testing. Clinicians can now offer DNA-based dietary recommendations backed by peer-reviewed science.

In September 2025, Myriad partnered with SOPHiA GENETICS to develop a liquid biopsy companion diagnostic. This collaboration targets precision oncology using real-time genomic insights.

Components Covered:

  • Genotyping Kits
  • Whole Exome/Genome Test Kits
  • Biomarker Panels
  • Software & Reporting Platforms
  • Companion Mobile Apps
  • Other Components

Sample Types Covered:

  • Saliva
  • Blood
  • Hair
  • Buccal Swab
  • Other Sample Types

Deployment Modes Covered:

  • Direct-to-Consumer (DTC)
  • Clinically Administered
  • Research-Use-Only (RUO)
  • Pharmacy

Test Types Covered:

  • Nutrition Response
  • Pharmacogenomics
  • Micronutrient & Vitamin Metabolism
  • Weight Management & Obesity-related Panels
  • Fitness & Exercise Response Tests
  • Personalized Supplement Recommendation Engines
  • Other Test Types

Technologies Covered:

  • SNP Genotyping
  • Whole Genome Sequencing
  • Microarray
  • Next-Generation Sequencing
  • Other Technologies

Applications Covered:

  • Personalized Nutrition & Diet Planning
  • Clinical Nutrition Support
  • Weight Management Programs
  • Sports Performance & Athlete Optimization
  • Chronic Disease Risk Assessment (diabetes, CVD)
  • Research & Clinical Trials
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nutrigenomic Testing Kits Market, By Component

  • 5.1 Introduction
  • 5.2 Genotyping Kits
  • 5.3 Whole Exome/Genome Test Kits
  • 5.4 Biomarker Panels
  • 5.5 Software & Reporting Platforms
  • 5.6 Companion Mobile Apps
  • 5.7 Other Components

6 Global Nutrigenomic Testing Kits Market, By Sample Type

  • 6.1 Introduction
  • 6.2 Saliva
  • 6.3 Blood
  • 6.4 Hair
  • 6.5 Buccal Swab
  • 6.6 Other Sample Types

7 Global Nutrigenomic Testing Kits Market, By Deployment Mode

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (DTC)
  • 7.3 Clinically Administered
  • 7.4 Research-Use-Only (RUO)
  • 7.5 Pharmacy

8 Global Nutrigenomic Testing Kits Market, By Test Type

  • 8.1 Introduction
  • 8.2 Nutrition Response
  • 8.3 Pharmacogenomics
  • 8.4 Micronutrient & Vitamin Metabolism
  • 8.5 Weight Management & Obesity-related Panels
  • 8.6 Fitness & Exercise Response Tests
  • 8.7 Personalized Supplement Recommendation Engines
  • 8.8 Other Test Types

9 Global Nutrigenomic Testing Kits Market, By Technology

  • 9.1 Introduction
  • 9.2 SNP Genotyping
  • 9.3 Whole Genome Sequencing
  • 9.4 Microarray
  • 9.5 Next-Generation Sequencing
  • 9.6 Other Technologies

10 Global Nutrigenomic Testing Kits Market, By Application

  • 10.1 Introduction
  • 10.2 Personalized Nutrition & Diet Planning
  • 10.3 Clinical Nutrition Support
  • 10.4 Weight Management Programs
  • 10.5 Sports Performance & Athlete Optimization
  • 10.6 Chronic Disease Risk Assessment (diabetes, CVD)
  • 10.7 Research & Clinical Trials
  • 10.8 Other Applications

11 Global Nutrigenomic Testing Kits Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 23andMe
  • 13.2 AncestryDNA
  • 13.3 Nutrigenomix
  • 13.4 DayTwo
  • 13.5 Genova Diagnostics
  • 13.6 Quest Diagnostics
  • 13.7 Invitae
  • 13.8 Myriad Genetics
  • 13.9 Helix
  • 13.10 LifeDNA
  • 13.11 Viome
  • 13.12 Onegevity
  • 13.13 Atlas Biomed
  • 13.14 Coral Genomics
  • 13.15 Pathway Genomics
  • 13.16 Medichecks
  • 13.17 Biotronik
  • 13.18 NIPD Genetics
  • 13.19 Omixon

List of Tables

  • Table 1 Global Nutrigenomic Testing Kits Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nutrigenomic Testing Kits Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Nutrigenomic Testing Kits Market Outlook, By Genotyping Kits (2024-2032) ($MN)
  • Table 4 Global Nutrigenomic Testing Kits Market Outlook, By Whole Exome/Genome Test Kits (2024-2032) ($MN)
  • Table 5 Global Nutrigenomic Testing Kits Market Outlook, By Biomarker Panels (2024-2032) ($MN)
  • Table 6 Global Nutrigenomic Testing Kits Market Outlook, By Software & Reporting Platforms (2024-2032) ($MN)
  • Table 7 Global Nutrigenomic Testing Kits Market Outlook, By Companion Mobile Apps (2024-2032) ($MN)
  • Table 8 Global Nutrigenomic Testing Kits Market Outlook, By Other Components (2024-2032) ($MN)
  • Table 9 Global Nutrigenomic Testing Kits Market Outlook, By Sample Type (2024-2032) ($MN)
  • Table 10 Global Nutrigenomic Testing Kits Market Outlook, By Saliva (2024-2032) ($MN)
  • Table 11 Global Nutrigenomic Testing Kits Market Outlook, By Blood (2024-2032) ($MN)
  • Table 12 Global Nutrigenomic Testing Kits Market Outlook, By Hair (2024-2032) ($MN)
  • Table 13 Global Nutrigenomic Testing Kits Market Outlook, By Buccal Swab (2024-2032) ($MN)
  • Table 14 Global Nutrigenomic Testing Kits Market Outlook, By Other Sample Types (2024-2032) ($MN)
  • Table 15 Global Nutrigenomic Testing Kits Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 16 Global Nutrigenomic Testing Kits Market Outlook, By Direct-to-Consumer (DTC) (2024-2032) ($MN)
  • Table 17 Global Nutrigenomic Testing Kits Market Outlook, By Clinically Administered (2024-2032) ($MN)
  • Table 18 Global Nutrigenomic Testing Kits Market Outlook, By Research-Use-Only (RUO) (2024-2032) ($MN)
  • Table 19 Global Nutrigenomic Testing Kits Market Outlook, By Pharmacy (2024-2032) ($MN)
  • Table 20 Global Nutrigenomic Testing Kits Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 21 Global Nutrigenomic Testing Kits Market Outlook, By Nutrition Response (2024-2032) ($MN)
  • Table 22 Global Nutrigenomic Testing Kits Market Outlook, By Pharmacogenomics (2024-2032) ($MN)
  • Table 23 Global Nutrigenomic Testing Kits Market Outlook, By Micronutrient & Vitamin Metabolism (2024-2032) ($MN)
  • Table 24 Global Nutrigenomic Testing Kits Market Outlook, By Weight Management & Obesity-related Panels (2024-2032) ($MN)
  • Table 25 Global Nutrigenomic Testing Kits Market Outlook, By Fitness & Exercise Response Tests (2024-2032) ($MN)
  • Table 26 Global Nutrigenomic Testing Kits Market Outlook, By Personalized Supplement Recommendation Engines (2024-2032) ($MN)
  • Table 27 Global Nutrigenomic Testing Kits Market Outlook, By Other Test Types (2024-2032) ($MN)
  • Table 28 Global Nutrigenomic Testing Kits Market Outlook, By Technology (2024-2032) ($MN)
  • Table 29 Global Nutrigenomic Testing Kits Market Outlook, By SNP Genotyping (2024-2032) ($MN)
  • Table 30 Global Nutrigenomic Testing Kits Market Outlook, By Whole Genome Sequencing (2024-2032) ($MN)
  • Table 31 Global Nutrigenomic Testing Kits Market Outlook, By Microarray (2024-2032) ($MN)
  • Table 32 Global Nutrigenomic Testing Kits Market Outlook, By Next-Generation Sequencing (2024-2032) ($MN)
  • Table 33 Global Nutrigenomic Testing Kits Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 34 Global Nutrigenomic Testing Kits Market Outlook, By Application (2024-2032) ($MN)
  • Table 35 Global Nutrigenomic Testing Kits Market Outlook, By Personalized Nutrition & Diet Planning (2024-2032) ($MN)
  • Table 36 Global Nutrigenomic Testing Kits Market Outlook, By Clinical Nutrition Support (2024-2032) ($MN)
  • Table 37 Global Nutrigenomic Testing Kits Market Outlook, By Weight Management Programs (2024-2032) ($MN)
  • Table 38 Global Nutrigenomic Testing Kits Market Outlook, By Sports Performance & Athlete Optimization (2024-2032) ($MN)
  • Table 39 Global Nutrigenomic Testing Kits Market Outlook, By Chronic Disease Risk Assessment (diabetes, CVD) (2024-2032) ($MN)
  • Table 40 Global Nutrigenomic Testing Kits Market Outlook, By Research & Clinical Trials (2024-2032) ($MN)
  • Table 41 Global Nutrigenomic Testing Kits Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.